MANTUANO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.096
AS - Asia 996
EU - Europa 809
SA - Sud America 271
AF - Africa 58
OC - Oceania 8
Totale 4.238
Nazione #
US - Stati Uniti d'America 2.016
SG - Singapore 419
IT - Italia 298
BR - Brasile 219
CN - Cina 193
HK - Hong Kong 108
RU - Federazione Russa 100
VN - Vietnam 74
SE - Svezia 68
DE - Germania 66
FR - Francia 60
CA - Canada 56
FI - Finlandia 54
GB - Regno Unito 53
IN - India 40
BD - Bangladesh 26
CI - Costa d'Avorio 24
ID - Indonesia 24
NL - Olanda 24
ES - Italia 22
JP - Giappone 20
MX - Messico 19
AR - Argentina 13
IQ - Iraq 13
PL - Polonia 11
TR - Turchia 11
ZA - Sudafrica 11
UZ - Uzbekistan 10
PK - Pakistan 9
AT - Austria 7
AU - Australia 7
CO - Colombia 7
EC - Ecuador 7
PE - Perù 7
SA - Arabia Saudita 7
UA - Ucraina 7
EG - Egitto 6
MA - Marocco 6
CZ - Repubblica Ceca 5
VE - Venezuela 5
BE - Belgio 4
BO - Bolivia 4
DZ - Algeria 4
IE - Irlanda 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
KR - Corea 3
MY - Malesia 3
PY - Paraguay 3
AL - Albania 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
BH - Bahrain 1
CH - Svizzera 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LC - Santa Lucia 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 4.238
Città #
Ashburn 260
Singapore 246
Fairfield 172
Chandler 159
San Jose 144
Dallas 137
Hong Kong 105
Woodbridge 104
Cambridge 81
Houston 71
Beijing 67
Bari 65
Nyköping 65
Seattle 63
Wilmington 56
Los Angeles 43
Council Bluffs 40
Helsinki 40
Bitetto 38
New York 32
Bitonto 29
Victoria 27
Lauterbourg 26
Abidjan 24
Ann Arbor 22
Ho Chi Minh City 22
Jakarta 20
Milan 20
Lawrence 18
Roxbury 17
São Paulo 17
Hanoi 16
Munich 16
Brooklyn 15
Des Moines 15
Falkenstein 14
Santa Clara 14
Grottaglie 13
Inglewood 13
Montreal 13
Frankfurt am Main 12
Chennai 11
Chicago 11
Turku 11
London 10
Amsterdam 9
Buffalo 9
Nuremberg 9
Orem 9
Rio de Janeiro 9
Taranto 9
Tashkent 9
Tokyo 9
Denver 8
Mexico City 8
San Diego 8
Belo Horizonte 7
Campinas 7
Nanjing 7
The Dalles 7
Trieste 7
Warsaw 7
Atlanta 6
Dong Ket 6
Groningen 6
Johannesburg 6
North Bergen 6
Rome 6
Toronto 6
Brno 5
Columbus 5
Jiaxing 5
Nakano 5
Poplar 5
Portsmouth 5
Redwood City 5
Sennori 5
Shanghai 5
Aldeatejada 4
Ankara 4
Baghdad 4
Bauru 4
Boardman 4
Brussels 4
Dublin 4
Goiânia 4
Haiphong 4
Jeddah 4
Luton 4
Melbourne 4
Mumbai 4
Nanchang 4
Paris 4
Pescara 4
Phoenix 4
Shenyang 4
Turin 4
Vienna 4
Baku 3
Bishkek 3
Totale 2.725
Nome #
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 308
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 286
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 226
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 225
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 217
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 215
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 201
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 185
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 148
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 146
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 137
Synthetic lethality to overcome cancer drug resistance 135
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds 134
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 131
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 129
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 121
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 118
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 113
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 110
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 103
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 96
Effect of exercise on telomere length and telomere proteins expression in mdx mice 94
null 93
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 89
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 84
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 83
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 82
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 77
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 75
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 53
Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine 51
On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics 51
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 39
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 23
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 13
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 5
Totale 4.396
Categoria #
all - tutte 16.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 63 41 15
2021/2022180 16 13 3 1 2 15 18 0 16 16 31 49
2022/2023356 26 52 26 38 29 43 2 41 56 5 21 17
2023/2024179 8 34 8 14 15 34 2 14 4 16 10 20
2024/2025882 32 6 26 28 31 101 157 109 55 54 112 171
2025/20261.993 338 78 256 173 248 102 218 80 296 204 0 0
Totale 4.396